| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |